antitrypsin

(redirected from Alpha 1-antitrypsin)
Also found in: Wikipedia.

an·ti·tryp·sin

(an'tē-trip'sin),
A substance that inhibits or prevents the action of trypsin.

antitrypsin

an·ti·tryp·sin

(an'tē-trip'sin)
A substance that blocks the action of trypsin.

antitrypsin

See ALPHA-ANTITRYPSIN.
References in periodicals archive ?
Clinical and pathologic correlation in 96 patients with panniculitis, including 15 patients with deficient levels of alpha 1-antitrypsin.
Human alpha 1-antitrypsin (AAT), a serum glycoprotein, is one of the best-known models of serine protease inhibitors (serpins) superfamily [1, 17].
Tracy, a veterinary nurse, was diagnosed with alpha 1-antitrypsin when her daughter Hannah was just two.
Steven Tuffin, 27, of Maghull, was born with a rare genetic liver condition - alpha 1-antitrypsin deficiency.
The paper describes highly specific and efficient ZFN-mediated correction of a defective human A1 AT gene in iPSCs derived from skin cells from individuals with alpha 1-antitrypsin deficiency (A1ATD).
NASDAQ: SGMO) announced publication of a preclinical study demonstrating highly specific, functional correction of the alpha 1-antitrypsin (A1AT) gene defect in patient-derived induced pluripotent stem cells (iPSCs) using zinc finger nucleases (ZFNs).
Serum alpha 1-antitrypsin deficiency associated with the common S-type (glu264--val) mutation results from intracellular degradation of alpha 1-antitrypsin prior to secretion.
7 June 2011 - US biopharmaceutical company Halozyme Therapeutics Inc (NASDAQ: HALO) and US-based synthetic biology company Intrexon Corp signed yesterday a worldwide exclusive licensing agreement for the use of rHuPH20 (recombinant human hyaluronidase) in the development of a subcutaneous injectable formulation of Intrexon's recombinant human alpha 1-antitrypsin (rHuA1AT).
M2 EQUITYBITES-June 7, 2011-Halozyme Intrexon partnership to develop first subcutaneousrecombinant alpha 1-antitrypsin for A1AT deficiency(C)2011 M2 COMMUNICATIONS http://www.
The research is being applied to diseases such as cystic fibrosis, a genetic lung and liver disorder called alpha 1-antitrypsin deficiency, inherited metabolic disorders such as lysosomal storage disease, and a fatal progressive nerve disease called Canavan disease; as well as eye disorders such as